Helena Hansen et al., "Whiteout: How Racial Capitalism Changed the Color of Opioids in America" (U California Press, 2023)
Dec 5, 2024
auto_awesome
David Herzberg, co-author of the award-winning book "Whiteout," delves into the stark realities of racial capitalism's role in the opioid crisis. He discusses how U.S. drug policy perpetuates inequalities, with punitive measures targeting marginalized communities while privileging others. Herzberg reveals the historical roots of these disparities and critiques colorblind racism's impact. He advocates for a shift from punishment to compassion in drug policy, emphasizing the need to empower marginalized voices in the narrative surrounding addiction and recovery.
The concept of racial capitalism illustrates how economic systems exploit racial hierarchies, particularly evident in the biotech industry's practices today.
U.S. drug policy reflects a dual legal structure, criminalizing drug use in marginalized communities while offering care to white populations for similar issues.
Media narratives shape public perception of addiction, often stigmatizing non-white drug users while granting empathy to white users, perpetuating systemic racism.
Deep dives
The Role of Racial Capitalism
Racial capitalism, a term coined by Cedric Robinson, describes an economic system where wealth is generated through the exploitation of cheap labor organized along racial lines. In the context of the contemporary biotech industry, this exploitation extends beyond labor to include racialized consumption patterns, especially evident in U.S. drug policy. The punitive legal system criminalizes drug use predominantly in black and brown communities while providing compassionate medical care to middle-class white populations for similar offenses. This systemic divide reveals the deep-rooted racial hierarchies that persist in the modern economy.
Historical Linkages of Drug Policy
The book explores the historical ties between American slavery and the modern drug policy landscape, illustrating how systems of racial capitalism evolved. It describes how drug markets have been segregated since the end of slavery, where white consumers accessed regulated, safer drugs while marginalized communities were pushed into prohibitory markets. The authors trace the implications of this division, emphasizing the tragic irony of white communities suddenly facing addiction crises associated with drugs that had been demonized in black and brown neighborhoods for decades. Such historical patterns underscore the continuous cycle of exploitation and inequality in drug policy.
The Opioid Crisis and Racial Narratives
The opioid crisis serves as a focal point in the discussion of drug policy and racial narratives. The book outlines the treatment and perception of different drugs, illustrating how opioids were initially marketed to white populations as safe medications, while those using heroin faced stigma and criminalization. Notably, the narrative shift regarding drug addiction, where empathy is shown towards white users while similar behaviors in non-white communities are labeled as moral failings, showcases the entrenched racial biases in social responses. The authors argue that such segmented responses perpetuate systemic racism within healthcare and law enforcement.
Media Influence and Public Narrative
Media plays a significant role in shaping public perceptions of drug use and addiction, often portraying marginalized communities in a negative light. Traditional narratives have historically emphasized moral failings related to drug use among non-white populations while framing addiction within white communities as a medical issue deserving of compassion. However, there is a hopeful shift as a new generation of journalists seeks alternative narratives, often informed by lived experiences, which challenge the status quo. These changes in storytelling are crucial for creating social awareness and promoting more equitable drug policies.
The Future of Drug Policy and Racial Justice
Looking ahead, the podcast emphasizes the potential for collective civil rights activism around drug policy that acknowledges intersectional issues of race and class. The authors highlight the risk that current political climates may lead to renewed punitive measures targeting marginalized communities, suggesting that such shifts may hinder progress in dealing with drug-related issues. However, grassroots movements advocating for harm reduction and restorative justice offer hope, emphasizing empathy and respect for those affected by addiction. The engagements from these movements could ultimately lead to more effective, equitable solutions for drug policy reform.
The phrase "racial capitalism" was used by Cedric Robinson to describe an economy of wealth accumulation extracted from cheap labor, organized by racial hierarchy, and justified through white supremacist logics. Now, in the twenty-first century, the biotech industry is the new capitalist whose race-based exploitation engages not only labor but racialized consumption. This arrangement is upheld through US drug policy, which over the past century has created a split legal system—one punitive system that criminalizes drug use common among Black, Brown, and lower-income communities and another system characterized by compassion and care that medicalizes, and thus legalizes, drug use targeted to middle-class White people.
In the award-winning book Whiteout: How Racial Capitalism Changed the Color of Opioids in America(U California Press, 2023), a trio of authors—Helena Hansen, Jules Netherland, and David Herzberg—explain how this arrangement came to pass, what impacts it has, and what needs to be done. This remarkable book won the 2023 Rachel Carson Book Prize from the Society for the Social Studies of Science.
This interview was a collaborative effort among Professor Laura Stark and graduate students at Vanderbilt University in the course, “American Medicine & the World.” Please email Laura with any feedback on the interview or questions about how to design collaborative interview projects for the classroom.